Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHAPE for Identifying Portal Hypertension
NCT06797193Recruiting
- Sponsor
- Mayo Clinic
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of perflutren lipid microspheres in Portal Hypertension (PH), sponsored by Mayo Clinic. Primary endpoints: Clinically significant portal hypertension (PH) and Diagnostic confidence. Started Mar 2025; status: recruiting.
02
Drugs
perflutren lipid microspheres
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT06797193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06797193.